Wednesday, December 19, 2012 - SAMUEL ÉMOND - FM 103.3
The acquired company is based in Brossard and has been operating for 25 years.
It operates specifically in the manufacture and management of natural products and glass vials.
This announcement comes just a few months after creating Agila-Jamp, the joint venture that specializes in generic injectable medication.
The acquisition of Laboratoire Suisse brings the number of JAMP Pharma employees to about 85 people and revenues of all brands together is about $50 million.